FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.07-8076com.
(The FASEB Journal. 2008;22:1226-1236.)
© 2008 FASEB
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Supplemental Data
Right arrow All Versions of this Article:
fj.07-8076comv1
22/4/1226    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spees, J. L.
Right arrow Articles by Prockop, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spees, J. L.
Right arrow Articles by Prockop, D. J.
(The FASEB Journal. 2008;22:1226-1236.)
© 2008 FASEB

Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension

Jeffrey L. Spees*,{ddagger},1, Mandolin J. Whitney*, Deborah E. Sullivan{dagger}, Joseph A. Lasky{dagger}, Miguel Laboy{dagger}, Joni Ylostalo* and Darwin J. Prockop*

* Department of Medicine, Center for Gene Therapy and

{dagger} Section of Pulmonary Diseases, Critical Care, and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana, USA; and

{ddagger} Department of Medicine, Cardiovascular Research Institute, University of Vermont, Colchester, Vermont, USA

1Correspondence: Department of Medicine, Cardiovascular Research Institute, University of Vermont, 208 South Park Dr., Ste. 2, Colchester, VT 05446, USA. E-mail: jeffrey.spees{at}uvm.edu

Infusion of bone marrow stem or progenitor cells may provide powerful therapies for injured tissues such as the lung and heart. We examined the potential of bone marrow-derived (BMD) progenitor cells to contribute to repair and remodeling of lung and heart in a rat monocrotaline (MCT) model of pulmonary hypertension. Bone marrow from green fluorescent protein (GFP)-transgenic male rats was transplanted into GFP-negative female rats. The chimeric animals were injected with MCT to produce pulmonary hypertension. Significant numbers of male GFP-positive BMD cells engrafted in the lungs of MCT-treated rats. Microarray analyses and double-immunohistochemistry demonstrated that many of the cells were interstitial fibroblasts or myofibroblasts, some of the cells were hematopoietic cells, and some were pulmonary epithelial cells (Clara cells), vascular endothelial cells, and smooth muscle cells. A few BMD cells fused with pulmonary cells from the host, but the frequency was low. In the hypertrophied hearts of MCT-treated rats, we found a significant increase in the relative numbers of BMD cells in the right ventricle wall as compared with the left ventricle. Some of the BMD cells in the right ventricle were vascular cells and cardiomyocytes. We report BMD cardiomyocytes with a normal chromosome number, fusion of BMD cells with host cardiomyocytes, and, in some cases, nuclear fusion.—Spees, J. L., Whitney, M. J., Sullivan, D. E., Lasky, J. A., Laboy, M., Ylostalo, J., Prockop, D. J. Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension.


Key Words: stem cell • monocrotaline • cardiac hypertrophy




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Aslam, R. Baveja, O. D. Liang, A. Fernandez-Gonzalez, C. Lee, S. A. Mitsialis, and S. Kourembanas
Bone Marrow Stromal Cells Attenuate Lung Injury in a Murine Model of Neonatal Chronic Lung Disease
Am. J. Respir. Crit. Care Med., December 1, 2009; 180(11): 1122 - 1130.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. G. Frid, M. Li, M. Gnanasekharan, D. L. Burke, M. Fragoso, D. Strassheim, J. L. Sylman, and K. R. Stenmark
Sustained hypoxia leads to the emergence of cells with enhanced growth, migratory, and promitogenic potentials within the distal pulmonary artery wall
Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1059 - L1072.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. A. Johns and K. Yamaji-Kegan
Unveiling cell phenotypes in lung vascular remodeling
Am J Physiol Lung Cell Mol Physiol, December 1, 2009; 297(6): L1056 - L1058.
[Full Text] [PDF]


Home page
J AndrolHome page
S. Gur, P. J. Kadowitz, S. Thammasitboon, J. A. Lasky, and W. J. G. Hellstrom
Characterization of Erectile Function in Monocrotaline-Treated Pulmonary Hypertensive Rats
J Androl, September 1, 2009; 30(5): 495 - 504.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
K. C. Young, E. Torres, K. E. Hatzistergos, D. Hehre, C. Suguihara, and J. M. Hare
Inhibition of the SDF-1/CXCR4 Axis Attenuates Neonatal Hypoxia-Induced Pulmonary Hypertension
Circ. Res., June 5, 2009; 104(11): 1293 - 1301.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
B Eyden, S S Banerjee, P Shenjere, and C Fisher
The myofibroblast and its tumours
J. Clin. Pathol., March 1, 2009; 62(3): 236 - 249.
[Abstract] [Full Text] [PDF]


Home page
Ther Adv Respir DisHome page
D. Siniscalco, N. Sullo, S. Maione, F. Rossi, and B. D'Agostino
Review: Stem cell therapy: the great promise in lung disease
Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 173 - 177.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The Federation of American Societies for Experimental Biology.